International Stem Cell Co. (OTCMKTS:ISCO) Sees Significant Increase in Short Interest

International Stem Cell Co. (OTCMKTS:ISCO) saw a significant growth in short interest during the month of May. As of May 28th, there was short interest totalling 5,600 shares, a growth of 5,500.0% from the May 13th total of 100 shares. Based on an average daily trading volume, of 20,900 shares, the days-to-cover ratio is presently 0.3 days.

ISCO stock traded down $0.02 during mid-day trading on Friday, reaching $0.37. The company had a trading volume of 15,850 shares, compared to its average volume of 11,269. International Stem Cell has a one year low of $0.30 and a one year high of $1.08. The business has a 50-day moving average price of $0.52.

International Stem Cell Company Profile

International Stem Cell Corporation focuses on the development of therapeutic and biomedical products worldwide. The company's products are based on human parthenogenetic stem cells, a proprietary type of pluripotent stem cell. It develops various cell types, including neural stem cells for the treatment of Parkinson's disease and other central nervous system disorders; liver cells to treat various congenital and acquired liver diseases; and islet cells for the treatment of diabetes.

Read More: Non-Fungible Token (NFT) Explained

Receive News & Ratings for International Stem Cell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Stem Cell and related companies with MarketBeat.com's FREE daily email newsletter.